Lamivudine-13C,15N2, d2
Lamivudine-13C,15N2, d2 (BCH-189-13C,15N2, d2) is a 13C, 15N, and deuterium labeled Lamivudine. Lamivudine is an orally active and blood-brain barrier permeable nucleoside reverse transcriptase inhibitor (NRTI). Lamivudine inhibits HIV reverse transcriptase 1 and 2 and hepatitis B virus (HBV) reverse transcriptase[1][2][3][4].
Product Specifications
Product Name Alternative
BCH-189-13C,15N2, d2
UNSPSC
12352005
Target
HBV; HIV; Isotope-Labeled Compounds; Reverse Transcriptase
Type
Isotope-Labeled Compounds
Related Pathways
Anti-infection; Others
Applications
COVID-19-anti-virus
Field of Research
Infection
Solubility
10 mM in DMSO
Smiles
OC([2H])([2H])[C@@H]1O[C@H]([15N]2C=CC(N)=[15N][13C]2=O)CS1
Molecular Formula
C7 13CH9D2N 15N2O3S
Molecular Weight
234.25
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog